Induction of Forkhead Class box O3a and apoptosis by a standardized ginsenoside formulation, KG-135, is potentiated by autophagy blockade in A549 human lung cancer cells

다국어 초록 (Multilingual Abstract)

Background: KG-135, a standardized formulation enriched with Rk1, Rg3, and Rg5 ginsenosides, has been shown to inhibit various types of cancer cells; however, the underlying mechanisms are not fully understood.
In this study, we explored its effects in A549 human lung cancer cells to investigate the induction of Forkhead Class box O3a (FOXO3a) and autophagy.
Methods: Cell viability was determined by sulforhodamine B staining. Apoptosis and cell cycle distribution were analyzed using flow cytometry. The changes of protein levels were determined using Western blot analysis. Autophagy induction was monitored by the formation of acidic vesicular organelles stained with acridine orange.
Results: KG-135 effectively arrested the cells in G1 phase with limited apoptosis. Accordingly, a decrease of cyclin-dependent kinase-4, cyclin-dependent kinase-6, cyclin D1, and phospho-retinoblastoma protein, and an increase of p27 and p18 proteins were observed. Intriguingly, KG-135 increased the tumor suppressor FOXO3a and induced the accumulation of autophagy hallmark LC3-II and acidic vesicular organelles without an increase of the upstream marker Beclin-1. Unconventionally, the autophagy adaptor protein p62 (sequestosome 1) was increased rather than decreased. Blockade of autophagy by hydroxychloroquine dramatically potentiated KG-135-induced FOXO3a and its downstream (FasL) ligand accompanied by the cleavage of caspase-8. Meanwhile, the decrease of Bcl-2 and survivin, as well as the cleavage of caspase-9, were also drastically enhanced, resulting in massive apoptosis.
Conclusion: Besides arresting the cells in G1 phase, KG-135 increased FOXO3a and induced an unconventional autophagy in A549 cells. Both the KG-135-activated extrinsic FOXO3a/FasL/caspase-8 and intrinsic caspase-9 apoptotic pathways were potentiated by blockade of autophagy. Combination of KG- 135 and autophagy inhibitor may be a novel strategy as an integrative treatment for cancers.

참고문헌 (Reference)

1 Bartucci M, "Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy" 19 : 768-778, 2012

2 Kondo Y, "The role of autophagy in cancer development and response to therapy" 5 : 726-734, 2005

3 Mizushima N., "The pleiotropic role of autophagy: from protein metabolism to bactericide" 12 (12): 1535-1541, 2005

4 Ruvolo PP, "The Herculean task of killing cancer cells : suppression of FOXO3A in acute leukemia involves a hydra of multiple survival kinases" 11 : 2589-, 2012

5 Gunja N, "Survival after massive hydroxychloroquine overdose" 37 : 130-133, 2009

6 Kaminskyy VO, "Suppression of basal autophagy reduces lung cancer cell proliferation and enhances caspase-dependent and-independent apoptosis by stimulating ROS formation" 8 : 1032-1044, 2012

7 Kim YJ, "Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-beta1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance" 322 : 23-33, 2014

8 Cheong JH, "Stereoisomer-specific anticancer activities of ginsenoside Rg3 and Rh2 in HepG2 cells : disparity in cytotoxicity and autophagy-inducing effects due to 20(S)-epimers" 38 : 102-108, 2015

9 Puissant A, "Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation" 70 : 1042-1052, 2010

10 Wang CZ, "Red American ginseng : ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots" 73 : 669-674, 2007

11 Wong AS, "Recent advances in ginseng as cancer therapeutics : a functional and mechanistic overview" 32 : 256-272, 2015

12 Hyuck Jae Choi, "Protective Effect of Heat-processed Ginseng (Sun Ginseng) in the Adenine-induced Renal Failure Rats" 고려인삼학회 36 (36): 270-276, 2012

13 Lee WH, "Potentiation of etoposide-induced apoptosis in HeLa cells by co-treatment with KG-135, a quality-controlled standardized ginsenoside formulation" 294 : 74-81, 2010

14 Cheng CC, "Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells" 55 : 531-540, 2005

15 Mizushima N, "Methods for monitoring autophagy" 36 : 2491-2502, 2004

16 Feng Y, "Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling" 5 : e1088-, 2014

17 Traganos F, "Lysosomal proton pump activity : supravital cell staining with acridine orange differentiates leukocyte subpopulations" 41 : 185-194, 1994

18 Collins LG, "Lung cancer : diagnosis and management" 75 : 56-63, 2007

19 Yoo JH, "KG-135, enriched with selected ginsenosides, inhibits the proliferation of human prostate cancer cells in culture and inhibits xenograft growth in athymic mice." 289 : 99-110, 2010

20 Park SA, "KG-135 inhibits COX-2 expression by blocking the activation of JNK and AP-1 in phorbol ester-stimulated human breast epithelial cells" 1095 : 545-553, 2007

21 Jun Yeon Park, "Increase in apoptotic effect of Panax ginseng by microwave processing in human prostate cancer cells: in vitro and in vivo studies" 고려인삼학회 40 (40): 62-67, 2016

22 Mizushima N, "How to interpret LC3 immunoblotting" 3 : 542-545, 2007

23 Lee WH, "Heat-processed neoginseng, KG-135, down-regulates G1 cyclin-dependent kinase through the proteasome-mediated pathway in HeLa cells" 21 : 467-474, 2009

24 Klionsky DJ, "Guidelines for the use and interpretation of assays for monitoring autophagy" 8 : 445-544, 2012

25 An IS, "Ginsenoside Rh2 mediates changes in the microRNA expression profile of human non-small cell lung cancer A549 cells" 29 : 523-528, 2013

26 Wang L, "Ginsenoside Rg3 sensitizes human nonsmall cell lung cancer cells to gammaradiation by targeting the nuclear factor-kappaB pathway" 12 : 609-614, 2015

27 Zhao Y, "Expression of Foxo3a in non-Hodgkin’s lymphomas is correlated with cell cycle inhibitor p27" 81 : 83-93, 2008

28 Ferlay J, "Estimates of worldwide burden of cancer in 2008 : GLOBOCAN 2008" 127 : 2893-2917, 2010

29 Garcia-Navas R, "Depletion of L-arginine induces autophagy as a cytoprotective response to endoplasmic reticulum stress in human T lymphocytes" 8 : 1557-1576, 2012

30 Sasaki K, "Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells" 10 : 370-, 2010

31 Codogno P, "Canonical and noncanonical autophagy: variations on a common theme of self-eating?" 13 : 7-12, 2012

32 Jemal A, "Cancer statistics, 2010" 60 : 277-300, 2010

33 Choi KT, "Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng Meyer" 29 : 1109-1118, 2008

34 Sui X, "Autophagy and chemotherapy resistance : a promising therapeutic target for cancer treatment" 4 : 1-12, 2013

35 Mizushima N, "Autophagy : process and function" 21 : 2861-2873, 2007

36 Eskelinen EL, "Autophagy : a lysosomal degradation pathway with a central role in health and disease" 1793 : 664-673, 2009

37 de Bruin EC, "Apoptosis and nonapoptotic deaths in cancer development and treatment response" 34 : 737-749, 2008

38 Bi X, "Antitumor activity of three ginsenoside derivatives in lung cancer is associated with Wnt/beta-catenin signaling inhibition" 742 : 145-152, 2014

39 Yun TK, "Anticarcinogenic effect of Panax ginseng C.A. Meyer and identification of active compounds." 16 (16): S6-S18, 2001

40 Puissant A, "AMPK-and p62/SQSTM1-dependent autophagy mediate resveratrol-induced cell death in chronic myelogenous leukemia" 6 : 655-657, 2010

41 Zhang LH, "AD-1, a novel ginsenoside derivative, shows anti-lung cancer activity via activation of p38 MAPK pathway and generation of reactive oxygen species" 1830 : 4148-4159, 2013

42 Xiang YZ, "A comparison of the ancient use of ginseng in traditional Chinese medicine with modern pharmacological experiments and clinical trials" 22 : 851-858, 2008

43 Kim DG, "20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma todoxorubicin" 5 : 4438-4451, 2014